Navigation Links
PAP-4CD

ProductsPAP-4CD
Company Bio/Data Corporation
Item PAP-4CD
Features Chromogenic assay, von willebrand assay (Ristocetin cofactor), Platelet Aggregation: four channels allow simultaneous performance of a routine aggregation profile, automatic 0% - 100% baseline settings, reports slope value and final percent aggregation, prints aggregation patterns in real time. Leukocyte aggregation, Data Interface System, Heparin Induced Platelet Aggregation (HIPA) for Heparin-Induced Thrombocytopenia (HIT).
Description The PAP-4CD is a four channel platelet aggregation profiler combined with a stand alone data system. Operating in conjunction with Microsoft WindowsTM, the PAP-4CD has real time, four color display of tests, automatic storage of test results, plus simplified data retrieval and data management. Four test modes are available: chromogenic assays, von willebrand assay (Ristocetin cofactor), platelet aggregation and leukocyte aggregation. The PAP-4CD may also be used for the evaluation and confirmation of Heparin Induced Thrombocytopenia (HIT). Four channels allow four tests to be run simultaneously and independently. Select standard volumes or microvolume quantities to reduce sample and reagent consumption.
Info Bio/Data Corporation
Customer Service: (800) 257-3282
Web site: http://www.biodatacorp.com/

Related medicine products :

1. PAP-4CD
... Requires minimal cervical spine manipulation. Prevent ... or nasally. Cost effective alternative to X-ray. ... of the soft tissues in the neck. ... location of the trachea relative to the ...
... manipulation. Prevent dental and soft tissue damage. ... to X-ray. Light-guided intubation is based upon ... the neck. This technique takes advantage of ... to the esophagus. A well-defined, circumscribed glow ...
All endotracheal accessories are designed to ensure your technique. The Blue Line® intubation stylets feature a satin-smooth coating and are available in three sizes....
... Aaron manufactures two groups of flexible lighting ... and non-sterile in three different sizes 5", ... shaft portion of the light). These lights ... light is needed., ,The second group ...
Medicine Products:
(Date:6/23/2017)... ... 2017 , ... Studies show evidence that carotenoids and antioxidants derived either from ... these patients. , But how often do ophthalmologists and optometrists in Sweden recommend the ... of or with early symptoms of AMD? A study published recently in ...
(Date:6/23/2017)... ... 2017 , ... Everybody has their own personal preference when it comes to ... some people don't like it at all. FindaTopDoc took a look at what makes ... can give readers a taste of their deepest, darkest fantasies and has the ability ...
(Date:6/23/2017)... ... June 23, 2017 , ... Georgia State University will ... 20. , The two-day conference is focused on advancing scientific knowledge about the ... lives and eliminating racial breast cancer-related disparities. The conference theme is “Illuminating Actionable ...
(Date:6/23/2017)... ... June 23, 2017 , ... Ross Insurance ... With the Federal Emergency Management Agency’s (FEMA) recent update of flood zones, more ... 2012, the Biggert-Waters Act was enacted to reflect the actual risk in flood ...
(Date:6/23/2017)... ... June 23, 2017 , ... ... planning services to communities in the greater Chicago metropolitan area, is embarking on ... to underprivileged youth in Chicago. , Founded in 1897, Hephzibah Children’s Association is ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... 2017  Less than a month ago, amateur hackers ... companies, including hospital networks, in over 150 countries. ... the largest online extortion attempts ever recorded. With the ... is imperative that providers understand where the risks lie, ... — and many other very real cyber threats.  ...
(Date:6/7/2017)... 7, 2017  Novavax, Inc., (Nasdaq: NVAX ) ... 2 trials of its RSV F protein recombinant nanoparticle vaccine ... have been published in the journal Vaccine ... in prior scientific conferences). The Company previously announced top ... is developing the RSV F Vaccine with the goal of ...
(Date:6/3/2017)... INDIANAPOLIS , June 3, 2017  Eli ... today announced that results from the Phase 3 ... kinase (CDK)4 & 6 inhibitor, in combination with ... treatment with fulvestrant alone in women with hormone-receptor-positive ... advanced breast cancer who have relapsed or progressed ...
Breaking Medicine Technology: